These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2980553)

  • 1. Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.
    Beltramello A; Leonardi M; Biasizzo E; Piscitelli G
    Acta Radiol Suppl; 1986; 369():542-4. PubMed ID: 2980553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopamidol for intrathecal use in pediatric neuroradiology.
    Ruggiero R; Piscitelli G; Ambrosio A
    Acta Radiol Suppl; 1986; 369():532-6. PubMed ID: 2980550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of iopamidol in children: clinical and diagnostic results.
    Wells RG; Seidel FG; Sty JR; Swick HM
    Pediatr Radiol; 1988; 18(3):190-3. PubMed ID: 3368243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopamidol myelography: morbidity in patients with previous intolerance to iodine derivatives.
    Ebersold MJ; Houser OW; Quast LM
    J Neurosurg; 1991 Jan; 74(1):60-3. PubMed ID: 1984508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media.
    Oi H; Yamazaki H; Matsushita M
    Radiat Med; 1997; 15(1):23-7. PubMed ID: 9134581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with iopamidol, a non-ionic water-soluble contrast medium in brain computed tomography].
    Fukumoto T; Tone O; Tsuruoka S; Suzuki R; Tsuyumu M; Hiratsuka H; Inaba Y
    Rinsho Hoshasen; 1984 Sep; 29(9):1029-33. PubMed ID: 6513078
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose cervical CT myelography. How acceptable are adverse effects at this juncture?
    Wang H; Rosenbaum AE; Updike ML; Kumar AJ; Zinreich SJ; Ahn HS; Kim WS
    Acta Radiol Suppl; 1986; 369():539-41. PubMed ID: 2980552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures following myelography with iopamidol.
    Levey AI; Weiss H; Yu R; Wang H; Krumholz A
    Ann Neurol; 1988 Apr; 23(4):397-9. PubMed ID: 3382176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.
    Provinciali L; Ceravolo MG; Signorino M; Baroni M; Pasquini U; Cerrutti R; Salvolini U
    Neuroradiology; 1993; 35(7):483-6. PubMed ID: 8232868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of iohexol vs iopamidol in lumbar myelography. Clinical, electrophysiological and brain CT scan correlations.
    Floras P; Deliac P; Gross C; Jouet P; Paty J; Caille JM
    J Neuroradiol; 1990; 17(3):190-200. PubMed ID: 2286841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
    Bassi P; Cecchini A; Dettori P; Signorini E
    Neuroradiology; 1982; 24(2):85-90. PubMed ID: 7177375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambulatory radicular myelography with iopamidol].
    Andreula CF; Gentile MA; Lorusso A; De Blasi R; Cicchetti NF; Carella A
    Radiol Med; 1987 Sep; 74(3):191-3. PubMed ID: 3659426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography].
    Stoeter P; Bergleiter R; Schneider I; Kubina FG
    Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies on the diagnostic value of CT-myelography using a water-soluble contrast medium, metrizamide].
    Nagase J
    Nihon Seikeigeka Gakkai Zasshi; 1982 Nov; 56(11):1569-86. PubMed ID: 6761403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F; Ciccarelli R; Cirillo S; D'Auria T; Gambardella A; La Tessa G; Meoli S; Rotondo A; Santoro S
    Radiol Med; 1980 Apr; 66(4):203-10. PubMed ID: 7005985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of clearance of intrathecal iopamidol in the dog.
    Wilcox J; Evill CA; Sage MR
    Neuroradiology; 1986; 28(4):359-61. PubMed ID: 3762917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iotrolan versus iopamidol. A controlled double-blind study with lumbar myelography].
    Maier B; Gerber U; König M; Stetter G
    Radiologe; 1992 Aug; 32(8):393-6. PubMed ID: 1410326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.